Prescription drug abuse | Behavioral Healthcare Executive Skip to content Skip to navigation

Prescription drug abuse

The least you need to know about ARCOS

February 14, 2018  |  Julie Miller, Editor in Chief
blog

The DEA has launched an addition to its ARCOS tool. Now, drug manufacturers and distributors will be able to view more data in order to look for potential diversion of controlled substances.

Drug overdose deaths soar nationally but plateau in some Western states

January 8, 2018  |  Kaiser Health News
news

The opioid crisis on the East Coast and in the Midwest has fueled a national surge in drug deaths, even as fatal overdoses have decreased or remained stable in parts of the West, new federal data show.

DEA operation flags 26 potentially rogue pharmacies

December 6, 2017  |  Tom Valentino, Senior Editor
news

An operation conducted by the DEA’s Los Angeles field division has identified 26 pharmacies in southern California, Hawaii and Nevada that are suspected of violating the Controlled Substances Act.

Cost analysis backs immediate access to agonist drugs for opioid dependence

November 29, 2017  |  Gary A. Enos, Contributing Editor
article

A cost-effectiveness analysis using California data makes a strong case for significant public investment in methadone and buprenorphine treatment.

Opioid crisis update from the field

November 9, 2017  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH
blog

This week’s 2017 National Meeting of the American Public Health Association featured almost a dozen sessions on today’s opioid crisis. My commentary today seeks to provide an overview of where we currently stand in our national efforts to address this profound...

Florida insurer to cease OxyContin coverage

November 8, 2017  |  Tom Valentino, Senior Editor
news

Florida Blue announced it will cease coverage of OxyContin by January, following in the footsteps of Cigna.

Record-setting amount of prescriptions collected on Take Back Day

November 7, 2017  |  Tom Valentino, Senior Editor
news

More than 456 tons of unwanted medications were collected for safe disposal during the U.S. Drug Enforcement Administration’s 14th Prescription Drug Take Back Day.

Would involuntary commitment for addiction save lives?

November 2, 2017  |  Jill Sederstrom
article

Civil commitment for those who need addiction treatment could save lives, but hurdles impede implementation as states work through legal and ethical concerns.

Medicare places few restrictions on opioid prescribing

October 16, 2017  |  Tom Valentino, Senior Editor
article

A study released by researchers at Yale University shows one-third of opioid medications were prescribed with no limitations from Medicare plans.

Data shows patterns in opioid prescribing

September 30, 2017  |  Julie Miller, Editor in Chief
article

Researchers have identified patterns in opioid prescribing nationwide, noting that the variations discovered aren’t tied to clinical factors, but rather are tied to factors such as age or insurance source.

What if we treat drug overdoses like suicide attempts?

September 21, 2017  |  Patrick Gauthier
blog

If we could take the best parts of successful civil commitment—immediate treatment, coordinated care and discharge planning—perhaps this may be another way to prevent future drug overdoses.

Parents unaware of opioid risk for adolescents

September 18, 2017  |  Tom Valentino, Senior Editor
article

A study published by Caron Treatment Centers shows fewer parents talk with their children about the dangers of prescription painkillers than those that discuss alcohol, illegally obtained drugs or safe sex.

Pages

Subscribe to Prescription drug abuse